UK markets closed

BioPorto A/S (THOXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.75000.0000 (0.00%)
As of 09:36AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.7500
Open0.7500
BidN/A x N/A
AskN/A x N/A
Day's range0.7500 - 0.7500
52-week range0.6439 - 0.7500
Volume4,000
Avg. volume0
Market cap251.01M
Beta (5Y monthly)1.21
PE ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call

    August 8, 2022News release BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call COPENHAGEN, DENMARK and BOSTON, MA, USA, August 8, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S BioPorto A/S (BioPorto) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of kidney injury, announced today that in connection with the release of its Interim Report for the second quarter of 2022, the Company’s management team will host an online investor presentation on August

  • Globe Newswire

    BioPorto Achieves Targeted Enrollment in Clinical Study Supporting FDA De Novo Submission for The NGAL Test in the U.S.

    COPENHAGEN, Denmark and BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced its achievement of targeted subject enrollment for the third part of a 3-part clinical study to support a U.S. Food and Drug Administration (FDA) De Novo submission for use of The NGAL Test in identifying patients under the age of 22 at risk for Acute Kidney Injury (AKI). “We are very pleased to have reached the study’s planned enrollment of 600 patients by the end of Q2, as pre

  • Globe Newswire

    Moderated webcast with BioPorto’s management

    June 21, 2022News release Moderated webcast with BioPorto’s management COPENHAGEN, DENMARK and BOSTON, MA, USA, June 21, 2022, (GLOBE NEWSWIRE) -- BioPorto A/S (CPH:BIOPOR) (BioPorto) today provided details of a previously announced session with members of its management team. Tony Pare, CEO, and Neil Goldman, Executive VP & CFO, will participate in a webcast hosted by HC Andersen Capital (HCA) on Wednesday, June 29, 2022, at 2:00 p.m. CET (8:00 a.m. ET). HCA will moderate questions from the par